Bob, Other short sellers are determined to stay put. Read what Herb Greenberg wrote today in TSC (I know you read the column already).
Regards,
Tom
This time the company said that its new auditors,
from KPMG, had taken a look at the books and
requested additional information regarding
Pediatrix's accounts receivables. Oh, and by the
way, KPMG said, Pediatrix's accounting of certain
acquisition-related costs wouldn't pass the SEC's
smell test.
In fact, the company added in its release, KPMG
told the company that Pediatrix may be required to
restate prior earnings. As a result, it concluded,
investors might want to ignore what the company
said only two days earlier about beating analyst
estimates. In fact, it says it doesn't know when
KPMG will be done with its audit.
Must be why, even after the stock's slide,
shortsellers claim they're in for the long haul, even
after the stock has lost more than half its value.
They're not convinced any medicine can cure what
ails this company.
|
